[HTML][HTML] Increasing consumption of antibiotics during the COVID-19 pandemic: implications for patient health and emerging anti-microbial resistance
The emergence of COVID-19 infection led to the indiscriminate use of antimicrobials without
knowing their efficacy in treating the disease. The gratuitous use of antibiotics for COVID-19 …
knowing their efficacy in treating the disease. The gratuitous use of antibiotics for COVID-19 …
[HTML][HTML] Prevalence, features and degree of association of oral lesions in COVID-19: a systematic review of systematic reviews
Regardless of rapidly emerging findings on oral lesions described in adult SARS-CoV-2-
positive subjects, the evidence level remains quite low and rather contrasting; therefore, the …
positive subjects, the evidence level remains quite low and rather contrasting; therefore, the …
[HTML][HTML] BA. 2.12. 1, BA. 4 and BA. 5 escape antibodies elicited by Omicron infection
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron sublineages BA.
2.12. 1, BA. 4 and BA. 5 exhibit higher transmissibility than the BA. 2 lineage 1. The receptor …
2.12. 1, BA. 4 and BA. 5 exhibit higher transmissibility than the BA. 2 lineage 1. The receptor …
[HTML][HTML] Effect of mRNA vaccine boosters against SARS-CoV-2 Omicron infection in Qatar
LJ Abu-Raddad, H Chemaitelly… - … England Journal of …, 2022 - Mass Medical Soc
Background Waning of vaccine protection against coronavirus disease 2019 (Covid-19) and
the emergence of the omicron (or B. 1.1. 529) variant of the severe acute respiratory …
the emergence of the omicron (or B. 1.1. 529) variant of the severe acute respiratory …
[HTML][HTML] Effects of previous infection and vaccination on symptomatic omicron infections
Background The protection conferred by natural immunity, vaccination, and both against
symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection with …
symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection with …
[HTML][HTML] Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus …
Background COVID-19 has overwhelmed health services globally. Oral antiviral therapies
are licensed worldwide, but indications and efficacy rates vary. We aimed to evaluate the …
are licensed worldwide, but indications and efficacy rates vary. We aimed to evaluate the …
[HTML][HTML] Introduction and expansion of the SARS-CoV-2 B. 1.1. 7 variant and reinfections in Qatar: A nationally representative cohort study
Background The epidemiology of the SARS-CoV-2 B. 1.1. 7 (or Alpha) variant is
insufficiently understood. This study's objective was to describe the introduction and …
insufficiently understood. This study's objective was to describe the introduction and …
[HTML][HTML] Cognitive impairment in young adults with post COVID-19 syndrome
E Herrera, MC Pérez-Sánchez, R San Miguel-Abella… - Scientific Reports, 2023 - nature.com
In this study, we aimed to examine different cognitive domains in a large sample of patients
with post COVID-19 syndrome. Two hundred and fourteen patients, 85.04% women, ranged …
with post COVID-19 syndrome. Two hundred and fourteen patients, 85.04% women, ranged …
[HTML][HTML] Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta SARS-CoV-2 infections: an observational study
Summary Background Protection against SARS-CoV-2 symptomatic infection and severe
COVID-19 of previous infection, mRNA two-dose vaccination, mRNA three-dose vaccination …
COVID-19 of previous infection, mRNA two-dose vaccination, mRNA three-dose vaccination …
Bivalent mRNA-1273.214 vaccine effectiveness against SARS-CoV-2 omicron XBB* infections
Effectiveness of the 50-μg mRNA-1273.214 bivalent vaccine against SARS-CoV-2 infection
was modest at 25% in a matched, retrospective, cohort study in Qatar comparing infection …
was modest at 25% in a matched, retrospective, cohort study in Qatar comparing infection …